Clinical Trial

Prospective Evaluation of OptiThyDose

Name: Prospective Evaluation of OptiThyDose — clinical trial record (NCT06864351)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

The aim of this multicentric, randomised, two-arms and single-blinded clinical trial is to prospectively evaluate OptiThyDose for Congenital hypothyroidism (CH) and Graves' disease (GD).

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-03-03.

Status change: Not Yet Recruiting → Recruiting 2025-09-01

Trial Details

NCT Number	NCT06864351
Lead Sponsor	University Children's Hospital Basel
Conditions	Thyroid Diseases, Congenital Hypothyroidism, Graves Disease
Enrollment	150 participants
Start Date	2025-08-28
Primary Completion	2028-05 (estimated)
Study Completion	2029-02 (estimated)
Updated on ClinicalTrials.gov	2025-09-03